{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T11:03:10Z","timestamp":1775300590674,"version":"3.50.1"},"reference-count":41,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>In 1980, smallpox became the first viral disease eradicated through vaccination.\nAfter the termination of the Smallpox Eradication Program, the global immunization of the\npopulation also ceased. Now, most people do not have any immunity against infections caused by\northopoxviruses. Emerging cases of zoonotic orthopox infections transferring to humans inspire the\nsearch for new small organic molecules possessing antiviral activity against orthopoxviruses.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>Here, we present the synthesis and evaluation of antiviral activity against one of the orthopoxviruses,\ni.e., Vaccinia virus, of hybrid structures containing 1-hydroxyimidazole and benzopyranone\nmoieties.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Novel 2-(3-coumarinyl)-1-hydroxyimidazoles were synthesized. Their prototropic tautomerism\nwas considered using 1H NMR spectroscopy. Antiviral activity of both new 2-(3-coumarinyl)-\n1-hydroxyimidazoles and previously described 2-(3-chromenyl)-1-hydroxyimidazoles against Vaccinia\nvirus was evaluated in Vero cell culture.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Newly synthesized 2-(3-coumarinyl)-1-hydroxyimidazoles existed in CDCl3 as a mixture of\nprototropic tautomers (N-hydroxyimidazole and imidazole N-oxide), transition to DMSO-d6 resulting\nin the prevalence of N-oxide tautomer. Evaluation of cytotoxicity and antiviral activity against Vaccinia\nvirus was performed in Vero cell culture. Compounds possessing high antiviral activity were\npresent in both series. It was demonstrated that the structure of heterocyclic substituent in position 2\nof imidazole impacted the cytotoxicity of substances under consideration. Thus, molecules containing\ncoumarin moiety exhibited lower toxicity than similarly substituted 2-(3-chromenyl)-1-\nhydroxyimidazoles.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Perspective virus inhibiting compounds possessing antiviral activity against Vaccinia\nvirus were revealed in the series of 2-(3-coumarinyl)-1-hydroxyimidazoles.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573406419666221125101053","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T07:51:38Z","timestamp":1669621898000},"page":"468-477","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Synthesis, Cytotoxicity and Antiviral Activity Against Vaccinia Virus of\n2-(3-Coumarinyl)-1-Hydroxyimidazoles"],"prefix":"10.2174","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1542-5565","authenticated-orcid":true,"given":"Polina A.","family":"Nikitina","sequence":"first","affiliation":[{"name":"Department of Fine Organic Synthesis and Chemistry of Dyes, D.I. Mendeleev University of Chemical Technology of\nRussia, Miusskaya sq., 9, Moscow, 125047, Russia"},{"name":"A.N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, Vavilova str., 28, Moscow, 119991,\nRussia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia M.","family":"Zakharova","sequence":"additional","affiliation":[{"name":"Department of Fine Organic Synthesis and Chemistry of Dyes, D.I. Mendeleev University of Chemical Technology of\nRussia, Miusskaya sq., 9, Moscow, 125047, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga A.","family":"Serova","sequence":"additional","affiliation":[{"name":"State Research Center of Virology and Biotechnology\n&#34;VECTOR,&#34; Novosibirsk Region, Koltsovo, 6300559, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolay I.","family":"Bormotov","sequence":"additional","affiliation":[{"name":"State Research Center of Virology and Biotechnology\n&#34;VECTOR,&#34; Novosibirsk Region, Koltsovo, 6300559, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleg Y.","family":"Mazurkov","sequence":"additional","affiliation":[{"name":"State Research Center of Virology and Biotechnology\n&#34;VECTOR,&#34; Novosibirsk Region, Koltsovo, 6300559, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larisa N.","family":"Shishkina","sequence":"additional","affiliation":[{"name":"State Research Center of Virology and Biotechnology\n&#34;VECTOR,&#34; Novosibirsk Region, Koltsovo, 6300559, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana Y.","family":"Koldaeva","sequence":"additional","affiliation":[{"name":"Department of Fine Organic Synthesis and Chemistry of Dyes, D.I. Mendeleev University of Chemical Technology of\nRussia, Miusskaya sq., 9, Moscow, 125047, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizaveta I.","family":"Basanova","sequence":"additional","affiliation":[{"name":"Department of Fine Organic Synthesis and Chemistry of Dyes, D.I. Mendeleev University of Chemical Technology of\nRussia, Miusskaya sq., 9, Moscow, 125047, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valery P.","family":"Perevalov","sequence":"additional","affiliation":[{"name":"Department of Fine Organic Synthesis and Chemistry of Dyes, D.I. Mendeleev University of Chemical Technology of\nRussia, Miusskaya sq., 9, Moscow, 125047, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/v12020138","volume":"12","author":"Meyer H.","year":"2020","unstructured":"Meyer H.; Ehmann R.; Smith G.L.; Smallpox in the post-eradication era. Viruses 2020,12(2),138","journal-title":"Viruses"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/v13010043","volume":"13","author":"Silva N.I.O.","year":"2020","unstructured":"Silva N.I.O.; de Oliveira J.S.; Kroon E.G.; Trindade G.S.; Drumond B.P.; Here, there, and everywhere: The wide host range and geographic distribution of zoonotic orthopoxviruses. Viruses 2020,13(1),43","journal-title":"Viruses"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ijid.2020.12.061","volume":"104","author":"Krankowska D.C.","year":"2021","unstructured":"Krankowska D.C.; Wo&#x17A;niak, P.A.; Cybula, A.; Izdebska, J.; Suchacz, M.; Samelska, K.; Wierci\u0144ska-Drapa\u0142o, A.; Szaflik, J.P. Cowpox: How dangerous could it be for humans? Case report. Int J Infect Dis 2021,104,239-241","journal-title":"Int J Infect Dis"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.4269\/ajtmh.19-0467","volume":"102","author":"Guagliardo S.A.J.","year":"2020","unstructured":"Guagliardo S.A.J.; Monroe B.; Moundjoa C.; Athanase A.; Okpu G.; Burgado J.; Townsend M.B.; Satheshkumar P.S.; Epperson S.; Doty J.B.; Reynolds M.G.; Dibongue E.; Etoundi G.A.; Mathieu E.; McCollum A.M.; Asymptomatic orthopoxvirus circulation in humans in the wake of a monkeypox outbreak among chimpanzees in cameroon. Am J Trop Med Hyg 2020,102(1),206-212","journal-title":"Am J Trop Med Hyg"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"604","DOI":"10.4269\/ajtmh.20-0589","volume":"104","author":"Hughes C.M.","year":"2021","unstructured":"Hughes C.M.; Liu L.; Davidson W.B.; Radford K.W.; Wilkins K.; Monroe B.; Metcalfe M.G.; Likafi T.; Lushima R.S.; Kabamba J.; Nguete B.; Malekani J.; Pukuta E.; Karhemere S.; Muyembe Tamfum J.J.; Okitolonda Wemakoy E.; Reynolds M.G.; Schmid D.S.; McCollum A.M.; A tale of two viruses: Coinfections of monkeypox and varicella zoster virus in the democratic republic of congo. Am J Trop Med Hyg 2021,104(2),604-611","journal-title":"Am J Trop Med Hyg"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/jmv.27306","volume":"94","author":"Sarwar S.","year":"2022","unstructured":"Sarwar S.; Maskey U.; Thada P.K.; Mustansir M.; Sarfraz A.; Sarfraz Z.; Re-emergence of monkeypox amidst delta variant concerns: A point of contention for public health virology? J Med Virol 2022,94(3),805-806","journal-title":"J Med Virol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e0010141","DOI":"10.1371\/journal.pntd.0010141","volume":"16","author":"Bunge E.M.","year":"2022","unstructured":"Bunge E.M.; Hoet B.; Chen L.; Lienert F.; Weidenthaler H.; Baer L.R.; Steffen R.; The changing epidemiology of human monkeypox\u2014A potential threat? A systematic review. PLoS Negl Trop Dis 2022,16(2),e0010141","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3390\/pathogens10040406","volume":"10","author":"Jos&#xE9; da Silva Domingos I.","year":"2021","unstructured":"Jos&#xE9; da Silva Domingos I.; Silva de Oliveira J.; Lorene Soares Rocha K.; Bretas de Oliveira D.; Geessien Kroon E.; Barbosa Costa G.; de Souza Trindade G.; Twenty years after bovine vaccinia in Brazil: Where we are and where are we going? Pathogens 2021,10(4),406","journal-title":"Pathogens"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.36233\/0507-4088-2019-64-5-206-214","volume":"64","author":"Shchelkunov S.N.","year":"2019","unstructured":"Shchelkunov S.N.; Shchelkunova G.A.; We should be prepared to smallpox re-emergence. Prob Virol, Russian j http:\/\/dx.doi.org\/10.36233\/0507-4088-2019-64-5-206-2142019,64(5),206-214","journal-title":"Prob Virol, Russian j"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1128\/JCM.41.9.4068-4070.2003","volume":"41","author":"Gallwitz S.","year":"2003","unstructured":"Gallwitz S.; Schutzbank T.; Heberling R.L.; Kalter S.S.; Galpin J.E.; Smallpox: Residual antibody after vaccination. J Clin Microbiol 2003,41(9),4068-4070","journal-title":"J Clin Microbiol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"e952","DOI":"10.1093\/milmed\/usaa084","volume":"185","author":"MacIntyre C.R.","year":"2020","unstructured":"MacIntyre C.R.; Reevaluating the risk of smallpox reemergence. Mil Med 2020,185(7-8),e952-e957","journal-title":"Mil Med"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.3390\/v2122803","volume":"2","author":"Andrei G.","year":"2010","unstructured":"Andrei G.; Snoeck R.; Cidofovir activity against poxvirus infections. Viruses 2010,2(12),2803-2830","journal-title":"Viruses"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.3390\/v2112409","volume":"2","author":"Jordan R.","year":"2010","unstructured":"Jordan R.; Leeds J.M.; Tyavanagimatt S.; Hruby D.E.; Development of ST-246&#xAE; for treatment of poxvirus infections. Viruses 2010,2(11),2409-2435","journal-title":"Viruses"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"105182","DOI":"10.1016\/j.antiviral.2021.105182","volume":"195","author":"Chan-Tack K.","year":"2021","unstructured":"Chan-Tack K.; Harrington P.; Bensman T.; Choi S.Y.; Donaldson E.; O\u2019Rear J.; McMillan D.; Myers L.; Seaton M.; Ghantous H.; Cao Y.; Valappil T.; Birnkrant D.; Struble K.; Benefit-risk assessment for brincidofovir for the treatment of smallpox: U.S. Food and drug administration\u2019s evaluation. Antiviral Res 2021,195,105182","journal-title":"Antiviral Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/14787210.2020.1819791","volume":"19","author":"Russo A.T.","year":"2021","unstructured":"Russo A.T.; Grosenbach D.W.; Chinsangaram J.; Honeychurch K.M.; Long P.G.; Lovejoy C.; Maiti B.; Meara I.; Hruby D.E.; An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications. Expert Rev Anti Infect Ther 2021,19(3),331-344","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1099\/jgv.0.000422","volume":"97","author":"Mazurkov O.Y.","year":"2016","unstructured":"Mazurkov O.Y.; Kabanov A.S.; Shishkina L.N.; Sergeev A.A.; Skarnovich M.O.; Bormotov N.I.; Skarnovich M.A.; Ovchinnikova A.S.; Titova K.A.; Galahova D.O.; Bulychev L.E.; Sergeev A.A.; Taranov O.S.; Selivanov B.A.; Tikhonov A.Y.; Zavjalov E.L.; Agafonov A.P.; Sergeev A.N.; New effective chemically synthesized anti-smallpox compound NIOCH-14. J Gen Virol 2016,97(5),1229-1239","journal-title":"J Gen Virol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10517-020-05034-x","volume":"170","author":"Mazurkov O.Y.","year":"2020","unstructured":"Mazurkov O.Y.; Shishkina L.N.; Bormotov N.I.; Skarnovich M.O.; Serova O.A.; Mazurkova N.A.; Chernonosov A.A.; Tikhonov A.Y.; Selivanov B.A.; Estimation of absolute bioavailability of the chemical substance of the anti-smallpox preparation NIOCH-14 in mice. Bull Exp Biol Med 2020,170(2),207-210","journal-title":"Bull Exp Biol Med"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11094-011-0613-z","volume":"45","author":"Zemtsova M.N.","year":"2011","unstructured":"Zemtsova M.N.; Zimichev A.V.; Trakhtenberg P.L.; Klimochkin Y.N.; Leonova M.V.; Balakhnin S.M.; Bormotov N.I.; Serova O.A.; Belanov E.F.; Synthesis and antiviral activity of several quinoline derivatives. Pharm Chem J 2011,45(5),267-269","journal-title":"Pharm Chem J"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s11094-012-0686-3","volume":"45","author":"Moiseev I.K.","year":"2012","unstructured":"Moiseev I.K.; Kon\u2019kov S.A.; Ovchinnikov K.A.; Kilyaeva N.M.; Bormasheva K.M.; Nechaeva O.N.; Leonova M.V.; Klimochkin Y.N.; Balakhnin S.M.; Bormotov N.I.; Serova O.A.; Belanov E.F.; Synthesis and antiviral activity of new adamantane derivatives. Pharm Chem J 2012,45(10),588-592","journal-title":"Pharm Chem J"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"113485","DOI":"10.1016\/j.ejmech.2021.113485","volume":"221","author":"Shiryaev V.A.","year":"2021","unstructured":"Shiryaev V.A.; Skomorohov M.Y.; Leonova M.V.; Bormotov N.I.; Serova O.A.; Shishkina L.N.; Agafonov A.P.; Maksyutov R.A.; Klimochkin Y.N.; Adamantane derivatives as potential inhibitors of p37 major envelope protein and poxvirus reproduction. Design, synthesis and antiviral activity. Eur J Med Chem 2021,221,113485","journal-title":"Eur J Med Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s11094-012-0698-z","volume":"45","author":"Rusinov V.L.","year":"2012","unstructured":"Rusinov V.L.; Egorov I.N.; Chupakhin O.N.; Belanov E.F.; Bormotov N.I.; Serova O.A.; Synthesis and antiviral activity of 1,2,4-triazine derivatives. Pharm Chem J 2012,45(11),655-659","journal-title":"Pharm Chem J"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1039\/C8MD00347E","volume":"9","author":"Sokolova A.S.","year":"2018","unstructured":"Sokolova A.S.; Yarovaya O.I.; Bormotov N.I.; Shishkina L.N.; Salakhutdinov N.F.; Synthesis and antiviral activity of camphor-based 1,3-thiazolidin-4-one and thiazole derivatives as Orthopoxvirus -reproduction inhibitors. MedChemComm 2018,9(10),1746-1753","journal-title":"MedChemComm"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"e1800153","DOI":"10.1002\/cbdv.201800153","volume":"15","author":"Sokolova A.S.","year":"2018","unstructured":"Sokolova A.S.; Yarovaya O.I.; Bormotov N.I.; Shishkina L.N.; Salakhutdinov N.F.; Discovery of a new class of inhibitors of vaccinia virus based on (\u2212)-borneol from Abies sibirica and (+)-camphor. Chem Biodivers 2018,15(9),e1800153","journal-title":"Chem Biodivers"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1039\/D0MD00108B","volume":"11","author":"Suslov E.V.","year":"2020","unstructured":"Suslov E.V.; Mozhaytsev E.S.; Korchagina D.V.; Bormotov N.I.; Yarovaya O.I.; Volcho K.P.; Serova O.A.; Agafonov A.P.; Maksyutov R.A.; Shishkina L.N.; Salakhutdinov N.F.; New chemical agents based on adamantane\u2013monoterpene conjugates against orthopoxvirus infections. RSC Medicinal Chemistry 2020,11(10),1185-1195","journal-title":"RSC Medicinal Chemistry"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"2100038","DOI":"10.1002\/ardp.202100038","volume":"354","author":"Sokolova A.S.","year":"2021","unstructured":"Sokolova A.S.; Kovaleva, K.S.; Yarovaya, O.I.; Bormotov, N.I.; Shishkina, L.N.; Serova, O.A.; Sergeev, A.A.; Agafonov, A.P.; Maksuytov, R.A.; Salakhutdinov, N.F. (+)-Camphor and (\u2212)\u2010borneol derivatives as potential anti-orthopoxvirus agents. Arch Pharm 2021,354(6),2100038","journal-title":"Arch Pharm"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.3390\/molecules26082235","volume":"26","author":"Sokolova A.S.","year":"2021","unstructured":"Sokolova A.S.; Putilova V.P.; Yarovaya O.I.; Zybkina A.V.; Mordvinova E.D.; Zaykovskaya A.V.; Shcherbakov D.N.; Orshanskaya I.R.; Sinegubova E.O.; Esaulkova I.L.; Borisevich S.S.; Bormotov N.I.; Shishkina L.N.; Zarubaev V.V.; Pyankov O.V.; Maksyutov R.A.; Salakhutdinov N.F.; Synthesis and antiviral activity of camphene derivatives against different types of viruses. Molecules 2021,26(8),2235","journal-title":"Molecules"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"e202100771","DOI":"10.1002\/cmdc.202100771","volume":"17","author":"Sokolova A.S.","year":"2022","unstructured":"Sokolova A.S.; Kovaleva K.S.; Kuranov S.O.; Bormotov N.I.; Borisevich S.S.; Zhukovets A.A.; Yarovaya O.I.; Serova O.A.; Nawrozkij M.B.; Vernigora A.A.; Davidenko A.V.; Khamitov E.M.; Peshkov R.Y.; Shishkina L.N.; Maksuytov R.A.; Salakhutdinov N.F.; Design, synthesis and biological evaluation of novel (+)-camphor and (-)-fenchone based derivatives as potente orthopoxviruses inhibitors. ChemMedChem 2022,17(12),e202100771","journal-title":"ChemMedChem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s11172-019-2467-6","volume":"68","author":"Nikitina P.A.","year":"2019","unstructured":"Nikitina P.A.; Bormotov N.I.; Shishkina L.N.; Tikhonov A.Y.; Perevalov V.P.; Synthesis and antiviral activity of 1-hydroxy-2-(2-hydroxyphenyl)imidazoles against vaccinia virus. Russ Chem Bull 2019,68(3),634-637","journal-title":"Russ Chem Bull"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3390\/molecules21020228","volume":"21","author":"Tsay S.C.","year":"2016","unstructured":"Tsay S.C.; Lin S.Y.; Huang W.C.; Hsu M.H.; Hwang K.; Lin C.C.; Horng J.C.; Chen I.C.; Hwu J.; Shieh F.K.; Leyssen P.; Neyts J.; Synthesis and structure-activity relationships of imidazole-coumarin conjugates against Hepatitis C virus. Molecules 2016,21(2),228","journal-title":"Molecules"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.virusres.2019.05.007","volume":"268","author":"Liu G.","year":"2019","unstructured":"Liu G.; Wang C.; Wang H.; Zhu L.; Zhang H.; Wang Y.; Pei C.; Liu L.; Antiviral efficiency of a coumarin derivative on spring viremia of carp virus in vivo. Virus Res 2019,268,11-17","journal-title":"Virus Res"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.virusres.2019.01.009","volume":"263","author":"Liu L.","year":"2019","unstructured":"Liu L.; Hu Y.; Lu J.; Wang G.; An imidazole coumarin derivative enhances the antiviral response to spring viremia of carp virus infection in zebrafish. Virus Res 2019,263,112-118","journal-title":"Virus Res"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.bmcl.2019.05.019","volume":"29","author":"Hu Y.","year":"2019","unstructured":"Hu Y.; Chen W.; Shen Y.; Zhu B.; Wang G.X.; Synthesis and antiviral activity of coumarin derivatives against infectious hematopoietic necrosis virus. Bioorg Med Chem Lett 2019,29(14),1749-1755","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"109657","DOI":"10.1016\/j.jfluchem.2020.109657","volume":"240","author":"Shcherbakov K.V.","year":"2020","unstructured":"Shcherbakov K.V.; Artemyeva M.A.; Burgart Y.V.; Saloutin V.I.; Volobueva A.S.; Misiurina M.A.; Esaulkova Y.L.; Sinegubova E.O.; Zarubaev V.V.; 7-Imidazolyl-substituted 4\u2032-methoxy and 3\u2032,4\u2032-dimethoxy-containing polyfluoroflavones as promising antiviral agents. J Fluor Chem 2020,240,109657","journal-title":"J Fluor Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/00397911.2010.523491","volume":"42","author":"Olomola T.O.","year":"2012","unstructured":"Olomola T.O.; Klein R.; Kaye P.T.; Convenient synthesis of 3-methylcoumarins and coumarin-3-carbaldehydes. Synth Commun 2012,42(2),251-257","journal-title":"Synth Commun"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1515\/hc-2017-0038","volume":"23","author":"Bochkov A.Y.","year":"2017","unstructured":"Bochkov A.Y.; Akchurin I.O.; Traven V.F.; A new facile way for the preparation of 3-formylcoumarins. Heterocycl Commun 2017,23(2),75-78","journal-title":"Heterocycl Commun"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s11094-017-1629-9","volume":"51","author":"Selivanov B.A.","year":"2017","unstructured":"Selivanov B.A.; Tikhonov A.Y.; Belanov E.F.; Bormotov N.I.; Kabanov A.S.; Mazurkov O.Y.; Serova O.A.; Shishkina L.N.; Agafonov A.P.; Sergeev A.N.; Synthesis and antiviral activity of 1-aryl-3-(3,5-dioxo-4-azatetracyclo[5.3.2.02,6.08,10]dodec-11-en-4-yl)ureas. Pharm Chem J 2017,51(6),439-443","journal-title":"Pharm Chem J"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1021\/jm061484y","volume":"50","author":"Bailey T.R.","year":"2007","unstructured":"Bailey T.R.; Rippin S.R.; Opsitnick E.; Burns C.J.; Pevear D.C.; Collett M.S.; Rhodes G.; Tohan S.; Huggins J.W.; Baker R.O.; Kern E.R.; Keith K.A.; Dai D.; Yang G.; Hruby D.; Jordan R.N; -(3,3a,4,4a,5,5a,6,6a-Octahydro-1,3-dioxo-4,6- ethenocycloprop[f]isoindol-2-(1 H)-yl)carboxamides: Identification of Novel Orthopoxvirus Egress Inhibitors. J Med Chem 2007,50(7),1442-1444","journal-title":"J Med Chem"},{"key":"ref=38","author":"Mironov A.N.","year":"2012","unstructured":"Mironov A.N.;  Rukovodstvo po provedeniyu doklinicheskikh issledovaniy lekarstvennykh sredstv 2012","journal-title":"Rukovodstvo po provedeniyu doklinicheskikh issledovaniy lekarstvennykh sredstv"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10593-017-2030-z","volume":"53","author":"Nikitina P.A.","year":"2017","unstructured":"Nikitina P.A.; Perevalov V.P.; Methods of synthesis and physicochemical properties of 1-hydroxyimidazoles, imidazole 3-oxides, and their benzoannulated analogs. Chem Heterocycl Compd 2017,53(2),123-149","journal-title":"Chem Heterocycl Compd"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1016\/j.tet.2013.02.039","volume":"69","author":"Nikitina P.A.","year":"2013","unstructured":"Nikitina P.A.; Kuz\u2019mina L.G.; Perevalov V.P.; Tkach I.I.; Synthesis and study of prototropic tautomerism of 2-(3-chromenyl)-1-hydroxyimidazoles. Tetrahedron 2013,69(15),3249-3256","journal-title":"Tetrahedron"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1071\/CH19222","volume":"72","author":"Nikitina P.A.","year":"2019","unstructured":"Nikitina P.A.; Koldaeva T.Y.; Mityanov V.S.; Miroshnikov V.S.; Basanova E.I.; Perevalov V.P.; Prototropic tautomerism and some features of the IR spectra of 2-(3-Chromenyl)-1-hydroxyimidazoles. Aust J Chem 2019,72(9),699-708","journal-title":"Aust J Chem"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406419666221125101053","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/211241\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406419666221125101053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T06:54:38Z","timestamp":1692428078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/211241\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406419666221125101053","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-06-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}